Julie Lynch

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

Michael D. Hill, Mayank Goyal, Bijoy K. Menon et al. · The Lancet · 2020 · 629 citations · Full text

Medicine, Neurology, Pharmacology +10

Pituitary dysfunction following cranial radiotherapy for adult‐onset nonpituitary brain tumours

Nikolaos Kyriakakis, Julie Lynch, Steve Orme et al. · Clinical Endocrinology · 2015 · 77 citations

Medicine, Endocrinology, Oncology +17

Impaired quality of life in patients with treated acromegaly despite long‐term biochemically stable disease: Results from a 5‐years prospective study

Nikolaos Kyriakakis, Julie Lynch, S. G. Gilbey et al. · Clinical Endocrinology · 2017 · 65 citations

Pharmacy, Internal Medicine, Clinical Pharmacology +13

Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance

Ross Hamblin, Ashley Vardon, Josephine Akpalu et al. · The Lancet Diabetes & Endocrinology · 2022 · 55 citations · Full text

Medicine, Endocrinology, Oncology +15

Assessment of Discrepancies Between Follow-up Infarct Volume and 90-Day Outcomes Among Patients With Ischemic Stroke Who Received Endovascular Therapy

Aravind Ganesh, Johanna M. Ospel, Bijoy K. Menon et al. · JAMA Network Open · 2021 · 41 citations · Full text

Medicine, Neurology, Surgery +16